Adamax is an emerging research compound that has drawn increasing attention from cognitive scientists and peptide researchers studying neuroprotective mechanisms and brain-derived neurotrophic factor (BDNF) signaling. As a nootropic peptide stack, Adamax represents a combination of Semax and Selank — two well-characterized neuropeptide analogs with overlapping but distinct mechanisms — formulated together for laboratory investigation into synergistic cognitive and anxiolytic signaling pathways. Researchers interested in how dual-pathway peptide stacks modulate neurotrophin cascades, stress-related behavior, and memory consolidation have increasingly turned to Adamax as a model compound.
This guide provides a thorough overview of what preclinical and mechanistic literature reveals about the individual components of Adamax, the rationale for their combination in research settings, and what scientists are currently examining in terms of their synergistic neurobiological activity. Whether you are exploring BDNF upregulation, GABAergic modulation, or cognitive stress models, the following discussion summarizes what peer-reviewed research has investigated thus far.
Research-only notice: This content is provided for educational discussion and laboratory research purposes only. No medical claims are made or implied. Adamax is not approved for human use and is intended strictly for in vitro and preclinical research applications.
Adamax - 10MG — Research-Grade Reference Material Adamax - 10MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Lipo-C 10ML
$115.00$86.25 with 1st order
Dihexa - 10MG
$90.00$67.50 with 1st order
Cartalax - 20MG
$50.00$37.50 with 1st order
Frequently Asked Questions
What is Adamax peptide?
Adamax is a research compound combining Semax and Selank — two synthetic neuropeptide analogs that have been studied separately for their effects on BDNF signaling, cognitive function, and anxiolytic behavior in preclinical models. The combination has been investigated for potential synergistic neuroprotective and cognitive-modulating effects in laboratory settings.
What mechanisms does Adamax research focus on?
Research into Adamax focuses on dual-pathway modulation: Semax has been studied for its BDNF upregulation and neuroprotective effects, while Selank has been examined for its anxiolytic properties via GABAergic and serotonergic modulation. Together, researchers investigate whether these mechanisms act synergistically in cognitive and stress models.
What is the difference between Semax and Selank in research?
Semax is an ACTH(4-7) analog studied primarily for its BDNF-stimulating and neuroprotective properties. Selank is a tuftsin-based peptide researched for its anxiolytic, memory-modulating, and immune-related signaling effects. Their mechanisms differ but are considered complementary by researchers studying dual cognitive-anxiolytic models.
Has Adamax been studied in cognitive research models?
While Adamax as a named stack has limited standalone literature, its components — Semax and Selank — have been individually studied in Russian and international preclinical research for memory consolidation, learning behavior, and stress-induced cognitive impairment. Researchers use the combination to explore potential additive or synergistic effects in cognitive study paradigms.
Is Adamax related to BDNF research?
Yes. Semax, a core component of Adamax, has been studied extensively for its ability to upregulate BDNF expression in rodent models. BDNF is a critical neurotrophin involved in neuroplasticity, synaptic consolidation, and neuroprotection. Adamax research often investigates whether combining Semax with Selank maintains or amplifies this BDNF-related signaling pathway.
What delivery formats are used for Adamax research?
Research literature on the component peptides includes intranasal delivery models, which are of interest due to direct nose-to-brain transport pathways. Intranasal administration has been studied for its ability to bypass the blood-brain barrier and deliver neuropeptides to central nervous system tissue more efficiently than peripheral routes.
Is Adamax the same as the Selank + Semax combo?
Yes. In the peptide research context, Adamax refers to a combined formulation of Semax and Selank. Each contributes distinct mechanistic profiles that researchers believe may interact through complementary neurotransmitter and neurotrophin pathways to produce effects worth studying in cognitive and anxiety models.
Where can researchers source Adamax for laboratory use?
Adamax is available from specialized peptide suppliers for research purposes. It should only be sourced from vendors offering third-party tested, high-purity compounds designated for laboratory and preclinical applications only — not for human consumption.
Understanding the Components: Semax and Selank
To understand Adamax as a research compound, it is essential to first examine what science has established about its two constituent peptides individually. As explored in the Selank peptide research guide on mechanisms and anxiolytic properties, Selank is a synthetic analog of the immunomodulatory peptide tuftsin, carrying the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and has been studied for its anxiolytic, nootropic, and immune-modulating properties in rodent models and limited clinical contexts in Russia.
Adamax - 10MG — Research-Grade Reference Material Adamax - 10MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…
View Research Data
Pfizer Hospira Bacteriostatic Water – 30 mL
$45.00$33.75 with 1st order
Lipo-C 10ML
$115.00$86.25 with 1st order
Dihexa - 10MG
$90.00$67.50 with 1st order
Cartalax - 20MG
$50.00$37.50 with 1st order
Semax, meanwhile, is an ACTH(4-7) proline-rich analog — a heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. As detailed in the Semax 10MG research guide on BDNF signaling and neuroprotective studies, Semax has been extensively investigated for its ability to stimulate BDNF expression, modulate dopaminergic and serotonergic systems, and protect neural tissue in ischemia and oxidative stress models. The combination of these two peptides in Adamax is designed to engage multiple neurobiological targets simultaneously — a key reason researchers find it a compelling subject for stack-based study designs.
Semax: BDNF Upregulation and Neuroprotection
Preclinical studies on Semax have repeatedly demonstrated its capacity to elevate BDNF levels in hippocampal and cortical tissue. BDNF plays a foundational role in long-term potentiation (LTP) — the synaptic strengthening process believed to underlie memory formation and retention. Rat models subjected to stressful cognitive tasks have shown improved maze performance following Semax administration, with corresponding BDNF elevations in relevant brain regions. Additionally, research in ischemic stroke models has investigated Semax for neuroprotective gene expression changes, with studies suggesting reduced apoptotic signaling in neural tissue under hypoxic conditions.
Selank: Anxiolytic Modulation and Memory Consolidation
Selank research has focused predominantly on its interaction with GABAergic systems, particularly its ability to modulate GABA-A receptor sensitivity without producing the dependence profiles associated with classical benzodiazepines. Studies in rodent anxiety models, including elevated plus maze and open field testing, have demonstrated anxiolytic-like behavioral outcomes. Importantly for cognitive research, Selank has also been studied for its effects on enkephalin degradation, memory consolidation under stress, and modulation of interleukin signaling — suggesting overlapping immune-neuromodulatory roles that are increasingly relevant in neuroinflammation research paradigms.
Adamax 5MG for research applications →
Rationale for the Adamax Combination in Research Models
The scientific rationale for studying Semax and Selank together — rather than as isolated compounds — centers on the hypothesis that their distinct mechanisms may act synergistically to produce a more comprehensive nootropic and neuroprotective profile. Researchers categorize this as a complementary dual-pathway model: Semax activates neurotrophin signaling (BDNF pathway) while Selank tempers anxiogenic interference in cognitive processing through GABAergic and serotonergic modulation. Together, they may allow researchers to study a state in which neural growth and stabilization signals are elevated while stress-related cognitive disruption is attenuated.
This kind of stack research has become increasingly relevant as discussed in guides covering the cognitive peptide showdown between Selank, Semax, and Dihexa — where comparisons between cognitive-targeting compounds highlight the growing interest in multi-mechanism approaches to understanding neural plasticity, learning behavior, and neuroprotection in preclinical settings.
Dual-Pathway Neurotrophin and Anxiolytic Research
In laboratory stress-cognition interaction models, researchers have used combined administration paradigms to examine whether Selank’s anxiolytic properties can prevent stress-induced BDNF suppression — a phenomenon well-documented in chronic stress rodent studies. The working hypothesis in some research designs is that Selank may preserve the neuromodulatory environment necessary for Semax-stimulated BDNF activity to express itself fully. This creates an interesting experimental framework where the two peptides are not simply additive, but potentially mutually protective in their mechanisms.
Neuroinflammation and Cognitive Stress Models
Both Semax and Selank have been independently studied in neuroinflammation contexts. Semax has been shown in some preclinical studies to influence expression of genes associated with inflammatory response regulation, while Selank has demonstrated effects on interleukin-6 (IL-6) and other inflammatory cytokine profiles in cell culture models. Researchers studying conditions involving neuroinflammatory components — such as cognitive impairment under chronic stress or aging models — find the combined Adamax framework compelling for examining whether dual peptide co-administration can modulate these cascades more effectively than either compound alone.
Selank & Semax 20MG Nasal Spray for research →
Intranasal Delivery in Adamax Research
A significant feature of Adamax research methodology is the focus on intranasal delivery. Both Semax and Selank were originally developed and studied using nasal administration routes, and this remains the predominant delivery model in the literature. The nose-to-brain pathway, mediated by olfactory and trigeminal neural routes, allows neuropeptides to reach central nervous system targets more directly than systemic administration, bypassing first-pass hepatic metabolism and reducing peripheral dilution. This has made intranasal peptide delivery an important area of research, as explored in the Ipamorelin nasal spray research guide on intranasal delivery applications.
For Adamax specifically, intranasal models allow researchers to study CNS-targeted delivery of both components simultaneously, observing how co-administration via the nasal route influences BDNF expression, behavioral anxiety markers, and cognitive task performance in rodent models. This adds an important pharmacokinetic dimension to Adamax research that is distinct from injectable paradigms and allows for more naturalistic CNS modeling.
Olfactory Pathway and CNS Targeting
Studies examining olfactory epithelium transport mechanisms have suggested that peptides administered intranasally can reach the olfactory bulb, cerebrospinal fluid, and deeper limbic structures within minutes. For Adamax research, this raises interesting questions about which brain regions receive the strongest initial peptide exposure — particularly relevant given that Semax’s BDNF effects have been documented prominently in hippocampal tissue, while Selank’s anxiolytic effects are associated with limbic system modulation, including the amygdala. Researchers investigating the spatial distribution of these peptides post-intranasal administration may find Adamax a uniquely tractable model for nose-to-brain transport research.
Semax 10MG Nasal Spray for research →
Selank 10MG Nasal Spray for research →
Adamax in the Context of Broader Nootropic Peptide Research
Within the landscape of cognitive research compounds, Adamax occupies an interesting niche. As discussed in the research guide to brain-targeting peptides and nootropic compounds, the field of nootropic peptide research has expanded considerably — with compounds ranging from BDNF modulators and cholinergic enhancers to neuropeptide analogs like Dihexa and Pinealon being studied across multiple cognitive domains.
Adamax fits within the category of neuropeptide-based nootropic stacks that attempt to simultaneously address both the neurochemical infrastructure for learning (via BDNF, neuroplasticity signaling) and the modulatory environment in which that learning occurs (via anxiolytic, anti-stress mechanisms). This positions it as a research subject with broad relevance across:
- Memory formation and consolidation studies in rodent behavioral models
- Stress-induced cognitive impairment paradigms
- Neuroplasticity and synaptic remodeling research
- Neuroinflammation and cytokine-mediated cognitive disruption models
- Nose-to-brain delivery pharmacokinetics
- Dual-peptide synergy and stack mechanism research
Researchers comparing Adamax to other cognitive peptides like Dihexa or Pinealon will note that while Dihexa targets HGF/c-Met receptor signaling for synaptogenesis, and Pinealon focuses on neuroprotection through epigenetic and mitochondrial pathways, Adamax is unique in its dual neurotrophin-anxiolytic design. This specificity makes it a valuable research tool for designs that require simultaneous interrogation of both BDNF-dependent plasticity and behavioral stress responses.
Comparison with Related Cognitive Peptides
| Feature | Adamax (Semax + Selank) | Dihexa | Pinealon |
|---|---|---|---|
| Primary mechanism studied | BDNF upregulation + GABAergic modulation | HGF/c-Met synaptogenesis signaling | Neuroprotection via epigenetic/mitochondrial pathways |
| Research delivery route | Intranasal (primary), injectable | Oral, subcutaneous | Intranasal, injectable |
| Anxiety model relevance | High (Selank component) | Low | Moderate |
| Neuroplasticity research focus | High (BDNF-dependent) | Very High (synaptogenesis) | Moderate |
| Neuroinflammation studies | Moderate (cytokine modulation) | Limited | High (oxidative stress models) |
| Stack combination research | Dual-peptide by design | Studied individually | Studied individually |
Choose Adamax research if…
- Your study design requires simultaneous investigation of BDNF upregulation and anxiolytic behavioral modulation
- You are modeling stress-induced cognitive impairment and need a compound with both neuroprotective and anti-anxiety mechanistic arms
- Your research involves intranasal peptide delivery and nose-to-brain transport pharmacokinetics
- You are examining dual-peptide synergy and the neuroscience of compound stacking
- Your work is situated within the GABAergic modulation or serotonergic regulation space alongside BDNF research
Choose Dihexa or Pinealon if…
- Your primary interest is in synaptogenesis via HGF receptor pathways (Dihexa)
- Your research focus is on neuroprotection in aging models, oxidative stress, or circadian neuropeptide signaling (Pinealon)
- You require a single-compound model without the complexity of a dual-peptide stack
Where These Fit in Your Research Library
For researchers building out a comprehensive cognitive peptide toolkit, Adamax is a natural inclusion alongside individual Semax and Selank compounds. Related products worth exploring for brain research include:
Adamax 5MG — combined Semax + Selank research compound →
Dihexa 10MG — HGF/c-Met synaptogenesis research →
Pinealon 20MG — neuroprotective peptide research →
For the full catalog of research-grade peptides available for laboratory study, visit the SourcePeptides research catalog.
Final Takeaway: What Adamax Research Tells Us
Adamax occupies a compelling position in the nootropic peptide research space as a dual-mechanism stack combining the BDNF-upregulating properties of Semax with the GABAergic and anxiolytic modulation of Selank. Preclinical studies on the individual components have generated a substantial body of evidence suggesting that both peptides are active in neuroplasticity, memory consolidation, stress response, and neuroinflammatory signaling pathways. The combination — delivered primarily via intranasal routes to target CNS regions directly — offers researchers a powerful model for studying how multi-pathway peptide stacking can influence cognitive behavior and neuroprotective gene expression simultaneously.
While the Adamax stack as a named compound has less standalone peer-reviewed literature than its individual components, the scientific rationale for its research use is strong and grounded in well-characterized mechanisms. Researchers investigating cognitive peptide synergy, dual-pathway neurological modulation, or intranasal CNS delivery will find Adamax a highly relevant compound for inclusion in contemporary laboratory study designs.
Sources & Further Reading
- Dolotov et al. — “Semax, an Analog of ACTH(4-7) with Cognitive Effects, Regulates BDNF and trkB Expression in the Rat Hippocampus” — Journal of Neurochemistry (2006)
- Seredenin et al. — “Anxiolytic Effects of Selank and Its Metabolites in Animal Models” — Bulletin of Experimental Biology and Medicine (2001)
- Levitskaya et al. — “Inhibition of Enkephalin-Degrading Enzymes by Selank Peptide” — Bulletin of Experimental Biology and Medicine (2005)
- PubMed Search — Semax BDNF Neuroprotection Studies (multiple authors)
- PubMed Search — Selank Anxiolytic GABAergic Modulation Studies (multiple authors)
